Overall Status

Not yet recruiting (1)

Recruiting (1)

Sign in for free

Phase

phase 2 (2)

Sponsor

National Cancer Institute (NCI) (1)

Niigata University Medical & Dental Hospital (1)

Collaborator

Merck Sharp & Dohme LLC (1)

Intervention

biospecimen collection (1)

ipilimumab (1)

mk-3475 (pembrolizumab) (1)

nivolumab (1)

Study Documents

Intervention Type

biological (1)

drug (1)

procedure (1)

Funder Type

NIH (1)

Other (1)

Study Type

Interventional (2)

ovarian squamous cell carcinoma

Showing 1 - 2 of 2

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Ovarian Squamous Cell Carcinoma Trial in Niigata (MK-3475 (pembrolizumab))

Not yet recruiting

Ovarian Squamous Cell Carcinoma

MK-3475 (pembrolizumab)

Niigata, Japan

Niigata University Medical & Dental Hosptal

Feb 20, 2023

Acinar Cell Carcinoma, Adenoid Cystic Carcinoma, Adrenal Cortical Carcinoma Trial in Guam, United States (Biospecimen

Recruiting

Acinar Cell Carcinoma
+93 more

Biospecimen Collection
+2 more

Birmingham, Alabama
+998 more

Aug 23, 2022